» Articles » PMID: 36072802

Rectosigmoid Sparing En Bloc Pelvic Resection for Fixed Ovarian Tumors: Surgical Technique and Perioperative and Oncologic Outcomes

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Sep 8
PMID 36072802
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Patients with advanced ovarian cancer often undergo en bloc rectosigmoid resection with total hysterectomy to completely debulk the pelvis. We describe a unique rectosigmoid sparing en bloc pelvic resection technique for fixed ovarian tumors infiltrating the colon wall.

Methods: From July 2020 to June 2021, 20 patients with advanced epithelial ovarian cancer (EOC) underwent rectosigmoid sparing en bloc pelvic resection successfully at our institution. We summarized our surgical technique and the peri-operative and oncological outcomes.

Results: Twenty cases with bowel infiltration achieved en bloc pelvic resection with rectosigmoid tumorectomy in a centripetal fashion. Only two patients required mucosal repair. None of the patients experienced any complications associated with en bloc resection. No pelvic recurrence occurred within the median follow-up time of 12 months.

Conclusion: Rectosigmoid sparing en bloc pelvic resection may be feasible for select patients with fixed ovarian tumors infiltrating the colon wall.

Citing Articles

Radical Oophorectomy for Advanced Ovarian Cancer: A Feasibility Study from Tertiary Care Cancer Centre in Eastern India.

Nanda S, Mahapatra M, Mohapatra J, Padhy A, Nayak B, Parija J J Obstet Gynaecol India. 2024; 74(3):265-270.

PMID: 38974740 PMC: 11224057. DOI: 10.1007/s13224-024-01945-1.

References
1.
Mourton S, Temple L, Abu-Rustum N, Gemignani M, Sonoda Y, Bochner B . Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2005; 99(3):608-14. DOI: 10.1016/j.ygyno.2005.07.112. View

2.
Fagotti A, Fanfani F, Ludovisi M, Lo Voi R, Bifulco G, Testa A . Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study. Gynecol Oncol. 2005; 96(3):729-35. DOI: 10.1016/j.ygyno.2004.11.031. View

3.
Vergote I, Trope C, Amant F, Kristensen G, Ehlen T, Johnson N . Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010; 363(10):943-53. DOI: 10.1056/NEJMoa0908806. View

4.
Bridges J, Leung Y, Hammond I, McCartney A . En bloc resection of epithelial ovarian tumors with concomitant rectosigmoid colectomy: the KEMH experience. Int J Gynecol Cancer. 1993; 3(4):199-202. DOI: 10.1046/j.1525-1438.1993.03040199.x. View

5.
Benedetti-Panici P, Maneschi F, Scambia G, Cutillo G, Greggi S, Mancuso S . The pelvic retroperitoneal approach in the treatment of advanced ovarian carcinoma. Obstet Gynecol. 1996; 87(4):532-8. DOI: 10.1016/0029-7844(95)00494-7. View